Alpha Cognition vs Scilex
ACOG and SCLX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACOG and SCLX compare
Alpha Cognition is the larger company, worth 14 times as much as Scilex ($181M against $13.2M).
Alpha Cognition keeps more of each dollar of sales as profit, with a net margin of −145% compared with −1470% at Scilex.
Alpha Cognition scores higher on the StockData Score (6 against 1 for Scilex), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACOG | SCLX |
|---|---|---|
| Size and price | ||
| Market cap | $181M | $13.2M |
| Share price | $8.30 | $1.56 |
| Change, 1 year | 35.6% | −91.7% |
| Change, 5 years | −63.3% | −99.6% |
| Beta (5Y) | 0.34 | 0.80 |
| Employees | 72 | 34 |
| StockData Score | ||
| Total score | 6 (better) | 1 |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 6 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 8.9× | 0.4× (better) |
| P/B | 3.7× | – |
| FCF yield | −17.1% | – |
| Fair value | $5.01 | – |
| Margin of safety | −65.7% | – |
| Growth | ||
| Revenue growth (TTM) | – | −28.5% |
| Revenue growth, 5Y average | – | 5.1% |
| Profitability | ||
| Gross margin | 92.9% | 161% (better) |
| Operating margin | −147% (better) | −1136% |
| Net margin | −145% (better) | −1470% |
| FCF margin | −153% | – |
| Return on equity | −72.9% | – |
| Return on invested capital | −684% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −22.2× |
| Current ratio | 7.13 (better) | 0.07 |
| Altman Z-score | 4.50 (better) | −12.74 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 48.7% | 9.8% |
| Held by insiders | 5.3% | – |
| Insider net buying, 12 months | $8.3M (better) | −$12.8M |
| Short interest, % of float | 2.0% | – |
Go deeper
- ACOG stock overview
- ACOG income statement
- ACOG valuation and score
- SCLX stock overview
- SCLX income statement
- SCLX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.